Patients and gonococcal isolates (n Å 783) from five sexually transmitted disease clinics in Ohio and western Pennsylvania were studied to investigate the spread of gonococci with decreased fluoroquinolone susceptibility. Among patients with gonorrhea, rates of infection with strains with decreased fluoroquinolone susceptibility (MIC of 0.125 -0.25 mg ciprofloxacin/mL) were 20% for Cleveland, 9% for Akron, 7% for Columbus, 1% for Toledo, and 0.5% for Pittsburgh. Persons infected with strains with decreased susceptibility were more likely than those with susceptible strains to be male and older; no significant differences in sex behaviors, residence of sex partners, or recent antibiotic use were detected. Prevalence of decreased susceptibility was not correlated with reported levels of community fluoroquinolone use. The Pro/IB-3 auxotype/serovar class accounted for 80% (44/55) of isolates with decreased susceptibility. Pro/IB-3 isolates from three cities had indistinguishable pulsed-field gel electrophoresis patterns, suggesting intercity spread of a clone.
Fluoroquinolones are safe, effective, orally administered, bility is not well established, but sporadic treatment failures have been reported [5, 6] . In strains with laboratory-selected single-dose therapies for gonococcal infection [1, 2] . Because of the development of gonococcal resistance to penicillins and resistance, decreased fluoroquinolone susceptibility is the result of the first of a series of mutations that cumulatively lead to tetracyclines, the Centers for Disease Control and Prevention (CDC) has recommended two fluoroquinolones, ciprofloxacin high-level resistance [12] , underscoring the potential public health importance of strains with decreased susceptibility. and ofloxacin, and two cephalosporins, ceftriaxone and cefixime, for gonorrhea treatment [3] . However, failures of fluoro-
The Gonococcal Isolate Surveillance Project (GISP) was developed in 1986 to monitor gonococcal antimicrobial susceptiquinolone treatment of gonococci infections that were not fully susceptible in vitro have been reported sporadically since the bilities [13] . Each month, susceptibilities of the first 20 urethral gonococcal isolates from men attending 24 clinics throughout early 1990s [4 -10] .
The following laboratory criteria for Neisseria gonorrhoeae the United States are determined. Before 1992, decreased susceptibility to ciprofloxacin in the United States was detected ciprofloxacin susceptibility have been proposed: Ciprofloxacin MICs of £0.06 mg/mL Å fully susceptible; 0.125 -0.5 mg/mL infrequently in the GISP sampling: 24 (0.3%) of 6947 isolates had ciprofloxacin MICs of 0.125 -0.5 mg/mL [14] . Since early Å decreased susceptibility; and §1.0 mg/mL Å resistant [ from each other by no more than a single fragment (figure 1).
serovar (A/S class) [19] . Pulsed-field gel electrophoresis (PFGE) PFGE patterns of 4 Columbus (figure 1, lanes 1 -4) and 3 patterns were determined using NheI and XbaI restriction enzymes Cleveland (figure 1, lanes 6, 7, and 9) Pro/IB-3 isolates were as previously described for randomly selected isolates (n Å 14) infected with susceptible strains to report a history of gonorrhea Analysis. We did a cross-sectional, case-control analysis of (67% vs. 54%, P Å .08). The 2 groups were similar with regard patients from cities with multiple individuals infected with strains to history of syphilis, number of sex partners in the previous with decreased ciprofloxacin susceptibility. The 5 women infected with gonococci with decreased susity: attendance at the Cleveland STD clinic (odds ratio [OR] Å 3.3, P õ .001), male sex (OR Å 2.5, P Å .07), and age ceptibility did not differ from women infected with susceptible strains in any of the behavioral or clinical characteristics (data §23 years (OR Å 1.8, P Å .08). Non-Hispanic black race/ ethnicity (OR Å 2.1, P Å .3) and reported history of gonorrhea not shown). They reported a total of 6 sex partners in the prior month, and none of them reported illicit drug use or the (OR Å 1.4, P Å .3) were not significantly associated with infection with these strains. exchange of money or drugs for sex.
In a multivariable logistic regression model of all patients Patients infected with gonococci with decreased ciprofloxacin susceptibility were somewhat less likely than other patients with gonorrhea, the following factors were associated with infection with strains with decreased ciprofloxacin susceptibilto have had sex partners from another city in the previous 30 days, and only control patients had had partners from out of state, but these differences were not statistically significant (table 1) . No patient reported a sex partner from outside the United States. Recent antibiotic use (described on the clinic form as ''current'' use in two clinics and use in the ''last 14 days'' in the third clinic) was infrequent, and no recent fluoroquinolone use was reported. The annual number of quinolone prescriptions per-person ranged from 0.04 to 0.11 (median and mean Å 0.07) in the 13 cities for which data were obtained (i.e., one fluoroquinolone [30] . Despite the absence of patients with cities each year). The annual per-person fluoroquinolone prescription rates in Cleveland (0.06), Pittsburgh (0.07), and Tosex partners from Canada in the present study, there may have been transmission between people in Ontario and Ohio that ledo (0.06) were at or below the median rates for the 13 cities.
resulted in the spread of this phenotype. Likewise, the possibility of importation from Southeast Asia, where such strains are Discussion also prevalent, cannot be excluded [10] . Infection with gonococci with decreased susceptibility may Many gonococcal infections caused by strains with decreased fluoroquinolone susceptibility have been linked to not be related to fluoroquinolone use directed at gonorrhea. Patients infected with these strains were not significantly more Southeast Asia [6, 8 -10, 24 -26] . While sporadic cases and at least 1 cluster of cases caused by apparently resistant organisms likely to report recent use of antibiotics, and none of the patients reported recent fluoroquinolone use. Public health clinics in [10, 15] have been reported in the United States, the Cleveland area was the first recognized focal area of endemic transmission Ohio do not use fluoroquinolones for gonorrhea treatment. Appropriate fluoroquinolone agents and doses would be likely to of gonococci with decreased fluoroquinolone susceptibility in this country [15, 16] . The prevalence of isolates with decreased cure infection in most patients with these strains with ciprofloxacin MICs of 0.125 -0.25 mg/mL [14]. However, gonociprofloxacin susceptibility in the Cleveland GISP sample peaked in 1994 at 17.5% (42/240 isolates), and it declined to cocci acquired following the last dose of a fluoroquinolone given for another indication, such as urinary or respiratory tract 5.4% by 1996. In contrast, the annual prevalence of such isolates at the other GISP sites combined has never been ú0.5%
infection, might then be exposed to sub-bactericidal levels of the antimicrobial, and strains with decreased susceptibility (CDC, unpublished data). This investigation documents the presence of such strains in other nearby cities as well as their could be selected in this fashion. However, compared with the 10 eastern and mid-western cities in which gonococci with persistence in Cleveland.
Most gonococcal isolates with decreased ciprofloxacin susdecreased fluoroquinolone susceptibility were not detected in GISP in 1992 -93, Cleveland (as well as Pittsburgh and Toledo) ceptibility from these cities appear to be closely related. With the exception of 1 isolate from Pittsburgh, the PFGE NheI and had annual fluoroquinolone prescription rates of 0.06 -0.07/ person, which is at or below the median rates for all cities XbaI patterns of all tested Pro/IB-3 isolates from Cleveland, Columbus, and Akron were indistinguishable from each other.
surveyed. These are ecologic data and postdate the initial identification of these gonococci, but they do not support the hyLikewise, Pro/IB-1 and Pro/IB-10 isolates differed from the Pro/IB-3 isolates by no more than one NheI or XbaI fragment.
pothesis that the overall level of community fluoroquinolone use was a major factor in the emergence or persistence of this Thus, these strains appear closely related [20, 21, 27, 28] , suggesting a common ancestor. The single isolate from Pittsphenotype. Strains with decreased ciprofloxacin susceptibility continued burgh differed from the other Pro/IB-3 isolates by three NheI and two XbaI fragments, and it most likely represents a genetito be isolated in Cleveland through 1996. As there appears to be no excess community use of fluoroquinolones and fluorocally distinct strain. Though PFGE was not done on the 2 Pro/IA-1, -2 isolates, which represent 1.8% (2/55) of all isolates quinolones have not been used in Ohio public health clinics for the treatment of gonorrhea, decreased fluoroquinolone suswith decreased ciprofloxacin susceptibility, these isolates may be genetically distant, as suggested by previous work comparceptibility may not contribute directly to their persistence in the population. Other biologic factors, such as higher transmising IA and IB strains [20] . In Ohio, strains with decreased ciprofloxacin susceptibility appear more homogeneous than sibility or longer duration of infectiousness, for which decreased fluoroquinolone susceptibility may simply be a marker, would be expected in an unselected sample of community strains [20, 27 -29] .
could favor a strain's persistence. However, no statistically significant differences in symptoms or their duration, time since There are two potential explanations for the emergence and persistence of gonococcal strains with decreased ciprofloxacin last sexual intercourse, or the examination (by microscopy) of the urethral discharge were found, suggesting no obvious biosusceptibility in these cities. Either this resistance phenotype was introduced from elsewhere or it arose locally. Although logic differences between these and susceptible strains that could be associated with their persistence. Patients infected 10.4% (43/403) of all patients in this study reported recent sex partners in another city, patients infected with gonococci with with strains with decreased susceptibility were more likely to be male and older. These characteristics have been associated decreased fluoroquinolone susceptibility were not more likely to have partners from another city or state, and none of the with infection with antimicrobial resistant gonococci in other studies and suggest that a core group population was infected patients reported partners from other countries. This study was conducted 2 years after these strains were first detected from with the resistant strains [31] . While women accounted for 24% of all patients with gonorrhea in this investigation, only Cleveland in GISP, and it was thus impossible to detect those events that led to the introduction of this resistance phenotype.
9% of the patients with gonorrhea with decreased fluoroquinolone susceptibility were women. These 5 women reported a However, isolates with ciprofloxacin MICs §0. have led to the successful spread and persistence of this pheno-
